EPISODE · Apr 10, 2026 · 33 MIN
Drug Fix: Leucovorin’s Resurrection, PhRMA’s Leadership Change
from Citeline Podcasts · host Norstella
Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss the details of the US Food and Drug Administration’s labeling update for leucovorin (:41), including GSK’s subsequent move to re-withdraw the application (19:45). They also grade the tenure of Steve Ubl as he prepares to leave as Pharmaceutical Research and Manufacturers of America president and CEO (21:02) and consider what the organization may seek in its next leader (27:07). #pharma #business More On These Topics From The Pink Sheet A Regulatory Pathway Of One: US FDA’s Wellcovorin Approval Would Be Hard To Scale: https://insights.citeline.com/pink-sheet/rare-diseases/a-regulatory-pathway-of-one-us-fdas-wellcovorin-approval-would-be-hard-to-scale-BHEAMFMG5BDJHJY5K6Z5OJF22A/ Outgoing PhRMA CEO Ubl Fought, Shaped Policies and Politics Around Price Controls: https://insights.citeline.com/pink-sheet/r-and-d/breaking-phrma-ceo-steve-ubl-leaving-later-this-year-2FNX2D5LE5GC3J2HARTZPHZDB4/
What this episode covers
Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss the details of the US Food and Drug Administration’s labeling update for leucovorin (:41), including GSK’s subsequent move to re-withdraw the application (19:45). They also grade the tenure of Steve Ubl as he prepares to leave as Pharmaceutical Research and Manufacturers of America president and CEO (21:02) and consider what the organization may seek in its next leader (27:07). #pharma #business More On These Topics From The Pink Sheet A Regulatory Pathway Of One: US FDA’s Wellcovorin Approval Would Be Hard To Scale: https://insights.citeline.com/pink-sheet/rare-diseases/a-regulatory-pathway-of-one-us-fdas-wellcovorin-approval-would-be-hard-to-scale-BHEAMFMG5BDJHJY5K6Z5OJF22A/ Outgoing PhRMA CEO Ubl Fought, Shaped Policies and Politics Around Price Controls: https://insights.citeline.com/pink-sheet/r-and-d/breaking-phrma-ceo-steve-ubl-leaving-later-this-year-2FNX2D5LE5GC3J2HARTZPHZDB4/
NOW PLAYING
Drug Fix: Leucovorin’s Resurrection, PhRMA’s Leadership Change
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m